Loading...
XNAS
SWAV
Market cap12bUSD
May 30, Last price  
334.75USD
Name

Shockwave Medical Inc

Chart & performance

D1W1MN
XNAS:SWAV chart
P/E
82.95
P/S
16.73
EPS
4.04
Div yield, %
Shrs. gr., 5y
7.26%
Rev. gr., 5y
126.45%
Revenues
730m
+49.11%
1,719,00012,263,00042,927,00067,789,000237,146,000489,733,000730,230,000
Net income
147m
-31.81%
-30,615,000-41,102,000-51,109,000-65,699,000-9,136,000215,996,000147,278,000
CFO
196m
+66.52%
-30,347,000-41,465,000-48,107,000-71,184,00015,036,000117,732,000196,053,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.

Related entities

Parent
Subsidiaries
SHOCKWAVE MEDICAL ITALY S.R.L.

Key people

Dan Puckett
Chief Financial Officer, Secretary · since 2018
Keith D. Dawkins
Chief Medical Officer · since 2019
Isaac Zacharias
Chief commercial Officer · since 2018
Marc-André Marcotte
Director · since 2018
Frederic Moll
Director · since 2016
F. Thomas Watkins
Director · since 2019
Colin Cahill
Independent Director · since 2015
Independent Director · since 2019
C. Raymond Larkin
Independent Chairman of the board · since 2019
IPO date
Mar 07, 2019
Employees
1,001
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT